Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 982, pseudogene (RNU6-982P) is classified as a pseudogene of the U6 small nuclear RNA (snRNA) family[5]. U6 snRNA is an essential non-coding RNA involved in pre-mRNA splicing as a core component of the spliceosome, where it facilitates intron excision from precursor mRNAs[1][3]. However, RNU6-982P, as a pseudogene, does not encode a functional RNA or protein product and is normally thought to lack biological activity. Such pseudogenes are likely remnants of gene duplication or retrotransposition events and are typically regarded as "non-functional" in the classical sense[4][5][6]. Nevertheless, recent studies show that some pseudogenes—including those related to small nuclear RNAs—can be transcribed to generate small regulatory RNAs in certain cellular contexts[4]. These small RNAs could theoretically participate in epigenetic regulation, such as promoting heterochromatin formation or gene silencing, but such functions are not established for RNU6-982P specifically. There is no information supporting a role in human disease, nor any known interacting drugs or biomarker status. Summary: - RNU6-982P is a pseudogene, not a therapeutic target or functional receptor/enzyme. - It is related by sequence homology to U6 small nuclear RNA—an essential spliceosomal RNA—but is not believed to participate in canonical splicing. - No known disease link, drug interaction, or established biological function for this particular pseudogene. - The presence of many U6-related pseudogenes is common in vertebrate genomes and may reflect evolutionary processes rather than current cellular function[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 982, pseudogene (RNU6-982P).